Bausch Health Companies Balance Sheet Health
Financial Health criteria checks 1/6
Bausch Health Companies has a total shareholder equity of $147.0M and total debt of $21.7B, which brings its debt-to-equity ratio to 14787.8%. Its total assets and total liabilities are $27.3B and $27.1B respectively. Bausch Health Companies's EBIT is $1.9B making its interest coverage ratio 1.3. It has cash and short-term investments of $1.7B.
Key information
14,787.76%
Debt to equity ratio
US$21.74b
Debt
| Interest coverage ratio | 1.3x |
| Cash | US$1.73b |
| Equity | US$147.00m |
| Total liabilities | US$27.12b |
| Total assets | US$27.27b |
Recent financial health updates
Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?
Nov 01
Is Bausch Health Companies (NYSE:BHC) A Risky Investment?
Jul 24Recent updates
Bausch Health: Repricing Continues As Deleveraging Gains Traction
Sep 11Improved Revenues Required Before Bausch Health Companies Inc. (NYSE:BHC) Stock's 30% Jump Looks Justified
Aug 16
Refinancing And New Product Launches Will Unlock Future Possibilities
Strategic initiatives in product launches and pipeline advancements suggest potential revenue growth by meeting unmet medical needs.Bausch Health Q4 Earnings Recap (Reiterating Buy Rating)
Feb 20Revenues Working Against Bausch Health Companies Inc.'s (NYSE:BHC) Share Price
Feb 18Bausch Health Companies: Improving Core Business Cures Its Bankruptcy Rumors
Dec 03There's No Escaping Bausch Health Companies Inc.'s (NYSE:BHC) Muted Revenues Despite A 28% Share Price Rise
Oct 10Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely
Sep 19Investors Don't See Light At End Of Bausch Health Companies Inc.'s (NYSE:BHC) Tunnel And Push Stock Down 28%
Aug 062 Red Alerts On Bausch Health Companies
Jul 25The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%
May 21Why Bausch Health Stock Plunged After Posting First-Quarter 2024 Results
May 07Bausch Health: A Timely Divestiture Is The Key To An Higher Valuation
Feb 24Bausch Health: $20bn Debt Is A Mighty Elephant In The Room
Nov 30Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?
Nov 01Bausch Health's Debt Dilemma: Strategic Decisions And Financial Metrics
Sep 24Is Bausch Health Companies (NYSE:BHC) A Risky Investment?
Jul 24Bausch + Lomb: $2.5bn M&A Deal Shows It Hasn't Learned From Parent's Mistakes
Jul 06What To Do After Bausch Health Stock Plunged By Nearly 9% Again
Jun 07Financial Position Analysis
Short Term Liabilities: BHC's short term assets ($6.5B) exceed its short term liabilities ($5.0B).
Long Term Liabilities: BHC's short term assets ($6.5B) do not cover its long term liabilities ($22.1B).
Debt to Equity History and Analysis
Debt Level: BHC's net debt to equity ratio (13612.9%) is considered high.
Reducing Debt: BHC's debt to equity ratio has increased from 4461.2% to 14787.8% over the past 5 years.
Debt Coverage: BHC's debt is not well covered by operating cash flow (6.9%).
Interest Coverage: BHC's interest payments on its debt are not well covered by EBIT (1.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/03 03:57 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bausch Health Companies Inc. is covered by 40 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Douglas Tsao | Barclays |
| Ardalan Arfaei | BMO Capital Markets Equity Research |
| Robert Hazlett | BMO Capital Markets U.S. (Historical) |